All patients with epithelial ovarian cancer should undergo germline genetic testing for BRCA1/2 mutations and other mutations associated with ovarian cancer due to the high rate of hereditary disease in this patient population and the availability of targeted therapies for patients with specific mutations [3,4,5]. Here, BRCA1 is linked to ovarian carcinoma.